Stocklytics Platform
Asset logo for symbol ASMB
Assembly Biosciences
ASMB63
$13.52arrow_drop_down0.29%-$0.04
Asset logo for symbol ASMB
ASMB63

$13.52

arrow_drop_down0.29%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Assembly Biosciences (ASMB) Stocklytics Forecast

Assembly Biosciences Inc (ASMB) has been steadily gaining attention in the stock market due to its promising potential in the biotechnology sector. With a focus on developing innovative therapies for diseases such as hepatitis B and C, the company has garnered significant interest from investors and analysts alike. The stock price of ASMB has seen fluctuations in recent years, but many experts believe that it has the potential for substantial growth in the coming years. Based on market trends and analysis, there is a positive outlook for ASMB stock in the future.
Analysts have provided bullish forecasts for the ASMB stock price, with some predicting a significant increase by 2023. Based on machine learning predictions and AI algorithms, ASMB is expected to reach new highs in the coming years. The average price target for ASMB stock by analysts is also optimistic, further reinforcing the positive sentiment surrounding the company. It is important to note that investing in any stock carries risks, and thorough research and analysis should be conducted before making any investment decisions.
add Assembly Biosciences  to watchlist

Keep an eye on Assembly Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Assembly Biosciences (ASMB) stock?

Analysts have set a target price of $15.79 for Assembly Biosciences (ASMB), based on forecasts from 7 analysts. The predicted price range extends from a high of $42 to a low of $1.5. This represents a potential increase of up to 210.65% and a decrease of -88.91% from the current price of $13.52. These forecasts are as of 2017 Nov 08.
help

What are the analyst ratings for Assembly Biosciences (ASMB) stock?

The analyst ratings for Assembly Biosciences (ASMB) are distributed as follows: 4 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Assembly Biosciences .
help

What is the AI price prediction for Assembly Biosciences (ASMB) stock?

At present, there is no AI or machine-learning-based price prediction available for Assembly Biosciences (ASMB) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level